It is worth noting that a higher AUC value indicates a stronger predictive capacity of FDX1 (Fig. 6P). Consequently, FDX1 exhibits a significant potential for prognostic prediction in glioma patients, with higher expressionlevels correlating with poorer patient outcomes. Here, FDX1 is linked to central nervous system cancer.